ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI

Clinical trial NCT03829475 · COMPLETED

Trial details

NCT number: NCT03829475
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases Clostridium Difficile Infection

Start date: 2020-01-01
Primary completion: 2023-08-03
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.